Skip to content
Catalyst

N(5)-ethyl-L-glutamineFinding

N(5)-ethyl-L-glutamine decreases PANSS positive subscale score

lowersVery limited evidenceFinding

01 · The sentence it was drawn from

“Compared with placebo, L-theanine augmentation was associated with reduction of anxiety (P = .015; measured by the HARS scale) and positive (P = .009) and general psychopathology (P < .001) scores (measured by the PANSS 3-dimensional model).”
Quoted verbatim from L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder: an 8-week, randomized, double-blind, placebo-controlled, 2-center study.
This finding among the 1 finding on its endpoint

N(5)-ethyl-L-glutamine

PANSS positive subscale score

lowers

Who
Chronic schizophrenia or schizoaffective disorder (DSM-IV); antipsychotic treatment continued in both arms as background; 8-week 2-center trial; PANSS 3-dimensional model
Dose studied
L-theanine 400 mg/d added to ongoing antipsychotic

Very limited evidencePMID 21208586 · 2011

02 · The study

Study
RCT
Duration
8 weeks

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7EQKFJDPHCKZ2T9WSJ7S7BN